FENNEC PHARMACEUTICALS INC. Income Statement
FENC|12 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$48M
FY2025
Gross Profit
N/A
FY2025
Operating Income
$3M
FY2025
Net Income
-$436,000
FY2025
FENNEC PHARMACEUTICALS INC. reported $48M in revenue and $436,000 in net loss for FY2025. Revenue has grown at a 308.9% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47.5M | $21.3M | $1.5M | $170.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | - | - | $86.0K | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | $1.4M | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $23.1M | $20.6M | $17.7M | $12.9M | $5.4M | $5.0M | $2.4M | $1.6M | $2.5M | $1.3M | $1.5M | $1.9M |
| R&D Expense | $307.0K | $56.0K | $3.5M | $5.1M | $5.0M | $1.9M | $472.0K | $256.0K | $357.0K | $597.0K | $2.1M | $1.0M |
| Operating Income | $2.6M | -$12.8M | -$22.6M | -$17.9M | -$10.4M | -$7.0M | -$2.9M | -$1.9M | -$2.9M | -$1.9M | -$3.6M | -$3.4M |
| Interest Expense | $4.1M | $3.4M | $195.0K | - | - | - | - | - | - | - | $0 | $0 |
| Income Tax | $365.0K | $365.0K | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - |
| Net Income | -$436.0K | -$16.0M | -$23.7M | -$18.1M | -$9.9M | -$7.0M | -$2.8M | -$659.0K | -$2.2M | $1.8M | -$37.0K | -$37.0K |
| EPS (Basic) | -$0.02 | -$0.60 | -$0.90 | -$0.76 | - | - | - | - | -$0.22 | $0.19 | -$0.21 | $0.20 |
| EPS (Diluted) | -$0.02 | -$0.60 | -$0.90 | -$0.76 | -$0.52 | -$0.47 | -$0.22 | -$0.06 | -$0.22 | $0.17 | -$0.21 | $0.19 |
| Shares Outstanding | 27.5M | 27.0M | 26.4M | 26.0M | 19.9M | 18.4M | 13.6M | 10.9M | 10.6M | 9.7M | 25.2M | 25.2K |
| Gross Margin | - | - | 94.4% | - | - | - | - | - | - | - | - | - |
| Operating Margin | 5.4% | -60.1% | -1471.6% | -10520.6% | - | - | - | - | - | - | - | - |
| Profit Margin | -0.9% | -75.5% | -1544.9% | -10652.4% | - | - | - | - | - | - | - | - |